Neoplasm by Morphology — Trials

Neoplasm by Morphology — Trials · CancerIndex

Clinical trials

Registered studies

52,671 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 201–250 of 3,586 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03258567	Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas	recruiting	Phase 2	40	National Cancer Institute (NCI)NIH	1	Sep 22, 2026	clinicaltrials
NCT04561206	Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma	recruiting	Phase 2	31	City of Hope Medical CenterOTHER	1	Sep 22, 2026	clinicaltrials